Entrada Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| WENTWORTH KORY JAMES | Chief Financial Officer | Option Exercise | 9,000 | $2.10 | $18,900 | 83,170 | Mar 15, 2024 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Sale | 4,086 | $12.31 | $50,299 | 74,170 | Mar 6, 2024 |
| Dowden Nathan J | President & COO | Sale | 1,826 | $12.32 | $22,496 | 137,204 | Mar 6, 2024 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Award / Grant | 30,900 | — | — | 80,471 | Mar 5, 2024 |
| Dowden Nathan J | President & COO | Tax Withholding | 1,486 | $12.28 | $18,248 | 139,030 | Mar 4, 2024 |
| Doshi Dipal | CEO | Tax Withholding | 1,391 | $13.37 | $18,598 | 345,424 | Mar 1, 2024 |
| Sethuraman Natarajan | Chief Scientific Officer | Tax Withholding | 1,505 | $12.28 | $18,481 | 209,032 | Mar 1, 2024 |
| Doshi Dipal | CEO | Sale | 1,000 | $15.00 | $15,000 | 243,279 | Feb 15, 2024 |
| Doshi Dipal | CEO | Sale | 1,000 | $15.99 | $15,990 | 244,279 | Jan 16, 2024 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Option Exercise | 10,206 | $2.10 | $21,433 | 59,777 | Dec 21, 2023 |
| Doshi Dipal | President and CEO | Sale | 1,000 | $15.00 | $15,000 | 245,279 | Dec 20, 2023 |
| Doshi Dipal | President and CEO | Sale | 1,000 | $16.23 | $16,230 | 246,279 | Nov 13, 2023 |
| Doshi Dipal | President and CEO | Sale | 1,000 | $15.00 | $15,000 | 247,279 | Oct 17, 2023 |
| Doshi Dipal | President and CEO | Sale | 1,000 | $15.00 | $15,000 | 248,279 | Sep 13, 2023 |
| Doshi Dipal | President and CEO | Award / Grant | 49,650 | — | — | 250,719 | Sep 5, 2023 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Sale | 904 | $13.45 | $12,159 | 49,617 | Sep 5, 2023 |
| Sethuraman Natarajan | Chief Scientific Officer | Award / Grant | 14,200 | — | — | 167,647 | Sep 5, 2023 |
| Dowden Nathan J | Chief Operating Officer | Sale | 59 | $14.01 | $827 | 48,168 | Sep 5, 2023 |
| KREHER NERISSA | Chief Medical Officer | Tax Withholding | 401 | $14.46 | $5,798 | 40,929 | Sep 1, 2023 |
| Doshi Dipal | President and CEO | Sale | 1,000 | $15.67 | $15,670 | 201,069 | Aug 14, 2023 |
| KREHER NERISSA | Chief Medical Officer | Sale | 6,898 | $14.14 | $97,538 | 27,130 | Aug 3, 2023 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Sale | 3,884 | $18.00 | $69,912 | 36,747 | Jul 11, 2023 |
| Dowden Nathan J | Chief Operating Officer | Sale | 3,200 | $18.00 | $57,600 | 39,273 | Jul 11, 2023 |
| Sethuraman Natarajan | Chief Scientific Officer | Sale | 14,852 | $18.04 | $267,930 | 153,447 | Jul 10, 2023 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Option Exercise | 8,790 | $2.10 | $18,459 | 36,747 | Jun 29, 2023 |
| Dowden Nathan J | Chief Operating Officer | Sale | 8,885 | $14.94 | $132,742 | 49,570 | Jun 22, 2023 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Sale | 8,907 | $15.17 | $135,119 | 27,957 | Jun 21, 2023 |
| Doshi Dipal | President and CEO | Sale | 2,000 | $13.71 | $27,420 | 202,069 | Apr 27, 2023 |
| Doshi Dipal | President and CEO | Sale | 2,092 | $18.01 | $37,677 | 204,069 | Apr 17, 2023 |
| Sethuraman Natarajan | Chief Scientific Officer | Sale | 3,961 | $18.00 | $71,298 | 171,325 | Apr 17, 2023 |
| Doshi Dipal | President and CEO | Sale | 1,800 | $14.63 | $26,334 | 256,011 | Mar 27, 2023 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Award / Grant | 28,400 | — | — | 44,909 | Mar 2, 2023 |
| Doshi Dipal | President and CEO | Award / Grant | 99,300 | — | — | 261,135 | Mar 2, 2023 |
| KREHER NERISSA | Chief Medical Officer | Award / Grant | 28,400 | — | — | 43,916 | Mar 2, 2023 |
| Sethuraman Natarajan | Chief Scientific Officer | Tax Withholding | 1,058 | $11.60 | $12,273 | 189,486 | Mar 1, 2023 |
| Dowden Nathan J | Chief Operating Officer | Tax Withholding | 1,028 | $11.60 | $11,925 | 72,655 | Mar 1, 2023 |
| Doshi Dipal | President and CEO | Award / Grant | 49,650 | — | — | 206,161 | Mar 1, 2023 |
| Sethuraman Natarajan | Chief Scientific Officer | Award / Grant | 14,200 | — | — | 175,286 | Mar 1, 2023 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Award / Grant | 14,200 | — | — | 27,957 | Mar 1, 2023 |
| KREHER NERISSA | Chief Medical Officer | Award / Grant | 14,200 | — | — | 27,130 | Mar 1, 2023 |
| Dowden Nathan J | Chief Operating Officer | Award / Grant | 14,200 | — | — | 58,455 | Mar 1, 2023 |
| Doshi Dipal | President and CEO | Sale | 2,000 | $12.00 | $24,000 | 161,835 | Feb 28, 2023 |
| Doshi Dipal | President and CEO | Sale | 2,000 | $12.00 | $24,000 | 163,835 | Jan 27, 2023 |
| Doshi Dipal | President and CEO | Sale | 2,410 | $15.02 | $36,198 | 165,835 | Jan 9, 2023 |
| KREHER NERISSA | Chief Medical Officer | Sale | 5,200 | $13.45 | $69,940 | 15,516 | Dec 30, 2022 |
| Doshi Dipal | President and CEO | Sale | 600 | $14.80 | $8,880 | 182,235 | Dec 28, 2022 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Sale | 4,550 | $18.95 | $86,223 | 16,509 | Dec 8, 2022 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Option Exercise | 2,910 | $2.10 | $6,111 | 19,419 | Dec 2, 2022 |
| Doshi Dipal | President and CEO | Sale | 2,000 | $13.91 | $27,820 | 182,835 | Nov 28, 2022 |
| WENTWORTH KORY JAMES | Chief Financial Officer | Sale | 200 | $18.10 | $3,620 | 16,509 | Nov 16, 2022 |